ÂÜÀòÂÒÂ×

Dr. Herman Scholtz, MD, has over 20 years of Pharmaceutical and CRO early drug development experience. Until recently he was the Global Vice President and General Manager, Clinical Pharmacology Services for Covance. During his tenure at Covance, he also served as the Chief Medical Officer and was a member of the Covance global Operating Committee and Scientific Council. Prior to joining Covance, Dr. Scholtz held several leadership positions in Early Drug Development over a 15-year career with PAREXEL International.

Dr. Scholtz qualified as a physician at the University of Pretoria, South Africa and qualified as an anesthesiologist at the University of the Free State in Bloemfontein, South Africa. He currently resides in Madison, WI (USA)